Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 1998
Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke
S A Loddick, X J Liu, Z X Lu, et al.
European Journal of Pharmacology
|
March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist
John W Adams, Juan Ramirez, Danny Ortuno, et al.
Rheumatology Advances in Practice
|
April 14, 2025
Osteoarthritis after major combat trauma: the Armed Services Trauma Rehabilitation Outcome Study
Fearghal P Behan, Alexander N Bennett, Fraje Watson, et al.
Endocrinology
|
January 19, 2008
A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release
Zhi-Liang Chu, Chris Carroll, Jean Alfonso, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 17, 2023
Association Between Combat-Related Traumatic Injury and Skeletal Health: Bone Mineral Density Loss Is Localized and Correlates With Altered Loading in Amputees: the Armed Services Trauma Rehabilitation Outcome (ADVANCE) Study
Louise McMenemy, Fearghal P Behan, Josh Kaufmann, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology
John W Adams, Juan Ramirez, Yunqing Shi, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 11, 2009
N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119
Zhi-Liang Chu, Chris Carroll, Ruoping Chen, et al.
Endocrinology
|
February 10, 2007
A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release
Zhi-Liang Chu, Robert M Jones, Hongmei He, et al.
British Journal of Sports Medicine
|
September 3, 2024
Developing an exercise intervention to minimise hip bone mineral density loss following traumatic lower limb amputation: a Delphi study
Fearghal P Behan, Anthony M J Bull, Belinda R Beck, et al.
The Journal of Biological Chemistry
|
April 25, 2007
Nicotinic acid receptor agonists differentially activate downstream effectors
Jeremy G Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 1998
Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke
S A Loddick, X J Liu, Z X Lu, et al.
European Journal of Pharmacology
|
March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist
John W Adams, Juan Ramirez, Danny Ortuno, et al.
Rheumatology Advances in Practice
|
April 14, 2025
Osteoarthritis after major combat trauma: the Armed Services Trauma Rehabilitation Outcome Study
Fearghal P Behan, Alexander N Bennett, Fraje Watson, et al.
Endocrinology
|
January 19, 2008
A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release
Zhi-Liang Chu, Chris Carroll, Jean Alfonso, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 17, 2023
Association Between Combat-Related Traumatic Injury and Skeletal Health: Bone Mineral Density Loss Is Localized and Correlates With Altered Loading in Amputees: the Armed Services Trauma Rehabilitation Outcome (ADVANCE) Study
Louise McMenemy, Fearghal P Behan, Josh Kaufmann, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology
John W Adams, Juan Ramirez, Yunqing Shi, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 11, 2009
N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119
Zhi-Liang Chu, Chris Carroll, Ruoping Chen, et al.
Endocrinology
|
February 10, 2007
A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release
Zhi-Liang Chu, Robert M Jones, Hongmei He, et al.
British Journal of Sports Medicine
|
September 3, 2024
Developing an exercise intervention to minimise hip bone mineral density loss following traumatic lower limb amputation: a Delphi study
Fearghal P Behan, Anthony M J Bull, Belinda R Beck, et al.
The Journal of Biological Chemistry
|
April 25, 2007
Nicotinic acid receptor agonists differentially activate downstream effectors
Jeremy G Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov, et al.
Page
of 8